Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Pol

Showing results (151-160 of 441) with videos related to

Pageof 45
Sort By:
Hepatology (Baltimore, Md.)|December 25, 2009
Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cellsMichelina Nascimbeni, Thomas Montange, Helen K W Law, et al.
Antiviral Therapy|May 12, 2009
Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02Philippe Halfon, Fabrice Carrat, Pierre Bédossa, et al.
World Journal of Gastroenterology|July 9, 2008
Pathological evolution of hepatitis C virus-"Healthy carriers"Rodolphe Sobesky, Pascal Lebray, Bertrand Nalpas, et al.
Journal of Hepatology|August 28, 2017
"Empirical" retreatment of patients with chronic hepatitis C who failed a first direct-acting antiviral-based regimenLaura Kramer, Anne Laurain, Philippe Sultanik, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 8, 2018
Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipientsStanislas Pol, Olivier Marion, Anaïs Vallet-Pichard, et al.
Gastroenterologie Clinique Et Biologique|March 10, 2007
Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational studyJean-François Cadranel, Jean-Louis Boujenah, Marc Bourlière, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2003
Veno-occlusive disease of the liver in renal transplant patientsAnaïs Vallet-Pichard, Jean-Philippe Rerolle, Hélène Fontaine, et al.
The Lancet Regional Health. Europe|December 24, 2021
Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS)Stanislas Pol, Fayssoil Fouad, Magali Lemaitre, et al.
Pharmacoepidemiology and Drug Safety|May 12, 2018
Signal detection on a patient cohort: A disproportionality analysis of the ANRS CO22 HEPATHER cohort to identify associations between direct acting antivirals and adverse events in patients with hepatitis C virus chronic infectionSarah F Feldman, Nathanaël Lapidus, Céline Dorival, et al.
AIDS (London, England)|March 5, 2008
Sexually transmitted hepatitis C virus superinfection in HIV/hepatitis C virus co-infected men who have sex with menJade Ghosn, Vincent Thibault, Constance Delaugerre, et al.
Pageof 45

Showing results (151-160 of 441) with videos related to

Sort By:
Pageof 45
Hepatology (Baltimore, Md.)|December 25, 2009
Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cellsMichelina Nascimbeni, Thomas Montange, Helen K W Law, et al.
Antiviral Therapy|May 12, 2009
Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02Philippe Halfon, Fabrice Carrat, Pierre Bédossa, et al.
World Journal of Gastroenterology|July 9, 2008
Pathological evolution of hepatitis C virus-"Healthy carriers"Rodolphe Sobesky, Pascal Lebray, Bertrand Nalpas, et al.
Journal of Hepatology|August 28, 2017
"Empirical" retreatment of patients with chronic hepatitis C who failed a first direct-acting antiviral-based regimenLaura Kramer, Anne Laurain, Philippe Sultanik, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 8, 2018
Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipientsStanislas Pol, Olivier Marion, Anaïs Vallet-Pichard, et al.
Gastroenterologie Clinique Et Biologique|March 10, 2007
Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational studyJean-François Cadranel, Jean-Louis Boujenah, Marc Bourlière, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2003
Veno-occlusive disease of the liver in renal transplant patientsAnaïs Vallet-Pichard, Jean-Philippe Rerolle, Hélène Fontaine, et al.
The Lancet Regional Health. Europe|December 24, 2021
Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS)Stanislas Pol, Fayssoil Fouad, Magali Lemaitre, et al.
Pharmacoepidemiology and Drug Safety|May 12, 2018
Signal detection on a patient cohort: A disproportionality analysis of the ANRS CO22 HEPATHER cohort to identify associations between direct acting antivirals and adverse events in patients with hepatitis C virus chronic infectionSarah F Feldman, Nathanaël Lapidus, Céline Dorival, et al.
AIDS (London, England)|March 5, 2008
Sexually transmitted hepatitis C virus superinfection in HIV/hepatitis C virus co-infected men who have sex with menJade Ghosn, Vincent Thibault, Constance Delaugerre, et al.
Pageof 45